RNA Sequencing Analysis May Offer More Accurate Diagnosis for Common Pediatric Cancer
A pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
Read MorePosted by Andy Lundin | Jan 30, 2024 | Leukemia |
A pilot study proposes a promising clinically applicable genomic assay for the diagnosis of a heterogeneous pediatric leukemia.
Read MorePosted by Andy Lundin | Jan 29, 2024 | Unknown Origin & Other Cancer Types |
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Prenatal Testing |
Natera has acquired certain assets from Invitae relating to its non-invasive prenatal screening and carrier screening business.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Diagnostic Technologies |
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read MorePosted by Andy Lundin | Jan 19, 2024 | Company News |
Myriad Genetics will acquire Intermountain Precision Genomics’ Precise Tumor Test, the Precise Liquid Test, and a CLIA-certified laboratory.
Read More